uz
Feedback
PathCast

PathCast

Kanalga Telegram’da o‘tish

Broadcasting & archiving the pathology knowledge base

Ko'proq ko'rsatish
1 891
Obunachilar
Ma'lumot yo'q24 soatlar
+37 kunlar
+1930 kunlar
Obunachilarni jalb qilish
Avgust '26
Avgust '26
+22
0 kanalda
Iyul '26
+27
0 kanalda
Get PRO
Iyun '26
+27
0 kanalda
Get PRO
May '26
+31
0 kanalda
Get PRO
Aprel '26
+23
0 kanalda
Get PRO
Mart '26
+16
0 kanalda
Get PRO
Fevral '26
+24
0 kanalda
Get PRO
Yanvar '26
+17
0 kanalda
Get PRO
Dekabr '25
+317
0 kanalda
Get PRO
Noyabr '250
0 kanalda
Get PRO
Oktabr '250
0 kanalda
Get PRO
Sentabr '250
0 kanalda
Get PRO
Avgust '250
0 kanalda
Get PRO
Iyul '250
0 kanalda
Get PRO
Iyun '250
0 kanalda
Get PRO
May '250
0 kanalda
Get PRO
Aprel '250
0 kanalda
Get PRO
Mart '250
0 kanalda
Get PRO
Fevral '250
0 kanalda
Get PRO
Yanvar '250
0 kanalda
Get PRO
Dekabr '24
+61
0 kanalda
Get PRO
Noyabr '24
+109
0 kanalda
Get PRO
Oktabr '24
+180
0 kanalda
Get PRO
Sentabr '24
+54
0 kanalda
Get PRO
Avgust '24
+50
0 kanalda
Get PRO
Iyul '24
+20
0 kanalda
Get PRO
Iyun '24
+12
0 kanalda
Get PRO
May '24
+20
0 kanalda
Get PRO
Aprel '24
+11
0 kanalda
Get PRO
Mart '24
+12
0 kanalda
Get PRO
Fevral '24
+22
0 kanalda
Get PRO
Yanvar '24
+34
0 kanalda
Get PRO
Dekabr '23
+22
0 kanalda
Get PRO
Noyabr '23
+18
0 kanalda
Get PRO
Oktabr '23
+14
0 kanalda
Get PRO
Sentabr '23
+17
0 kanalda
Get PRO
Avgust '23
+23
0 kanalda
Get PRO
Iyul '23
+21
0 kanalda
Get PRO
Iyun '23
+8
0 kanalda
Get PRO
May '23
+6
0 kanalda
Get PRO
Aprel '23
+10
0 kanalda
Get PRO
Mart '23
+8
0 kanalda
Get PRO
Fevral '23
+11
0 kanalda
Get PRO
Yanvar '23
+7
0 kanalda
Get PRO
Dekabr '22
+14
0 kanalda
Get PRO
Noyabr '22
+23
0 kanalda
Get PRO
Oktabr '22
+16
0 kanalda
Get PRO
Sentabr '22
+10
0 kanalda
Get PRO
Avgust '22
+33
0 kanalda
Get PRO
Iyul '22
+6
0 kanalda
Get PRO
Iyun '22
+10
0 kanalda
Get PRO
May '22
+11
0 kanalda
Get PRO
Aprel '22
+19
0 kanalda
Get PRO
Mart '22
+18
0 kanalda
Get PRO
Fevral '22
+31
0 kanalda
Get PRO
Yanvar '22
+248
0 kanalda
Get PRO
Dekabr '21
+2
0 kanalda
Get PRO
Noyabr '21
+10
0 kanalda
Get PRO
Oktabr '21
+10
0 kanalda
Get PRO
Sentabr '21
+5
0 kanalda
Get PRO
Avgust '21
+13
0 kanalda
Get PRO
Iyul '21
+12
0 kanalda
Get PRO
Iyun '21
+409
0 kanalda
Sana
Obunachilarni jalb qilish
Esdaliklar
Kanallar
27 Avgust+1
26 Avgust0
25 Avgust+2
24 Avgust+1
23 Avgust+1
22 Avgust0
21 Avgust+1
20 Avgust0
19 Avgust+1
18 Avgust+2
17 Avgust+1
16 Avgust0
15 Avgust0
14 Avgust+2
13 Avgust+1
12 Avgust0
11 Avgust0
10 Avgust0
09 Avgust0
08 Avgust+2
07 Avgust+1
06 Avgust+1
05 Avgust+1
04 Avgust+2
03 Avgust0
02 Avgust+1
01 Avgust+1
Kanal postlari
What's New in Colorectal Tumors (WHO 6th edition, 2026) WHO GI Tumors, 6th Edition - What's New? August 22, 2026 Dr. Amitabh Srivastava, MD Attending Pathologist Memorial Sloan Kettering Cancer Center, New York @PathCast

2
What's New in Gastroesophageal Tumors (WHO 6th edition, 2026) WHO GI Tumors, 6th Edition - What's New? August 22, 2026 Dr. El
What's New in Gastroesophageal Tumors (WHO 6th edition, 2026) WHO GI Tumors, 6th Edition - What's New? August 22, 2026 Dr. Elizabeth Montgomery, MD Professor of Pathology University of Miami Miller School of Medicine, Florida @PathCast
125
3
What's New in Neuroendocrine Tumors (WHO 6th edition, 2026) WHO GI Tumors, 6th Edition - What's New? August 22, 2026 Dr. Andr
What's New in Neuroendocrine Tumors (WHO 6th edition, 2026) WHO GI Tumors, 6th Edition - What's New? August 22, 2026 Dr. Andrew Bellizzi, MD Professor of Pathology & Cell Biology Columbia University irving Medical center, New York @PathCast
119
4
Gestational Trophoblastic Diseases ISGyP LiVE Journal Club August 19, 2026 @PathCast
Gestational Trophoblastic Diseases ISGyP LiVE Journal Club August 19, 2026 @PathCast
191
5
Beyond HER2-Negative Practical Interpretation, Scoring, and Reporting of Lower HER2 Expression in Metastatic Breast Cancer. M
Beyond HER2-Negative Practical Interpretation, Scoring, and Reporting of Lower HER2 Expression in Metastatic Breast Cancer. Michelle Shiller, DO, AP, CP, MGP, FACP discusses the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice. @PathCast
427
6
Uterine mesenchymal lesions ISGyP LiVE Journal Club Jun 17, 2026 @PathCast
Uterine mesenchymal lesions ISGyP LiVE Journal Club Jun 17, 2026 @PathCast
316
7
Liver Tumor Classification in the 6th Edition of the WHO Dr. Michael S. Torbenson, MD, Professor of Pathology Mayo Clinic, Ro
Liver Tumor Classification in the 6th Edition of the WHO Dr. Michael S. Torbenson, MD, Professor of Pathology Mayo Clinic, Rochester, USA, discusses @PathCast
633
8
ISGyP LiVE Journal Club Jun 17, 2026 @PathCast
ISGyP LiVE Journal Club Jun 17, 2026 @PathCast
508
9
The morphology-molecular gap in endometrial carcinoma: ambiguous histologies and challenging cases Divya Midha (India) ISGyP
The morphology-molecular gap in endometrial carcinoma: ambiguous histologies and challenging cases Divya Midha (India) ISGyP LiVE Slide Session May 14, 2026 @PathCast
499
10
High-Yield Molecular Pathology for Boards: Part 2 (Hematolymphoid Tumors) Dr. Jeremiah X. Karrs, DO Assistant Professor of Pa
High-Yield Molecular Pathology for Boards: Part 2 (Hematolymphoid Tumors) Dr. Jeremiah X. Karrs, DO Assistant Professor of Pathology and Laboratory Medicine Dartmouth Hitchcock Medical Center & Geisel School of Medicine at Dartmouth @PathCast
499
11
Common and not so common challenges: Intratumoral heterogeneity, mixed histology and subclonality in endometrial carcinoma -
Common and not so common challenges: Intratumoral heterogeneity, mixed histology and subclonality in endometrial carcinoma - Guidance for the practicing pathologist Jutta Huvila (Finland) ISGyP LiVE Webinar May 7, 2026 @PathCast
1
12
Common and not so common challenges: Intratumoral heterogeneity, mixed histology and subclonality in endometrial carcinoma -
Common and not so common challenges: Intratumoral heterogeneity, mixed histology and subclonality in endometrial carcinoma - Guidance for the practicing pathologist Jutta Huvila (Finland) ISGyP LiVE Webinar May 7, 2026 @PathCast
618
13
Evening Specialty Conference - Endocrine Pathology USCAP 115TH Annual Meeting MAKING CONNECTIONS @PathCast
Evening Specialty Conference - Endocrine Pathology USCAP 115TH Annual Meeting MAKING CONNECTIONS @PathCast
742
14
This concludes the USCAP Gynecologic Pathology: Practical Strategies for Modern Practice Series. Tap here for the first video of the series on Telegram or get it on Odysee here.
777
15
USCAP Gynecologic Pathology: Practical Strategies for Modern Practice Series Panel Discussion - Day 3 @PathCast
USCAP Gynecologic Pathology: Practical Strategies for Modern Practice Series Panel Discussion - Day 3 @PathCast
635
16
USCAP Gynecologic Pathology: Practical Strategies for Modern Practice Series Panel Discussion - Day 2 @PathCast
USCAP Gynecologic Pathology: Practical Strategies for Modern Practice Series Panel Discussion - Day 2 @PathCast
521
17
USCAP Gynecologic Pathology: Practical Strategies for Modern Practice Series Panel Discussion - Day 1 @PathCast
USCAP Gynecologic Pathology: Practical Strategies for Modern Practice Series Panel Discussion - Day 1 @PathCast
486
18
High-yield molecular pathology for boards - Part 1 (Solid tumors) Dr. Laura J. Tafe, MD Professor of Pathology and Laboratory
High-yield molecular pathology for boards - Part 1 (Solid tumors) Dr. Laura J. Tafe, MD Professor of Pathology and Laboratory Medicine Dartmouth Hitchcock Medical Center & Geisel School of Medicine at Dartmouth @PathCast
502
19
USCAP Platform and Poster Winners ISGyP LiVE Journal Club April 15, 2026 Moderators: Zehra Ordulu (USA) & Lulu Sun (USA) @Pat
USCAP Platform and Poster Winners ISGyP LiVE Journal Club April 15, 2026 Moderators: Zehra Ordulu (USA) & Lulu Sun (USA) @PathCast
553
20
USCAP Platform and Poster Winners ISGyP LiVE Journal Club April 15, 2026 Moderators: Zehra Ordulu (USA) & Lulu Sun (USA) @PathCast
1